🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
TSH
$TSHA
🔒 US EquitiesTaysha Gene Therapies Inc
AVG HISTORICAL GAP
+10.70%
MAX GAP RECORD
+105.68%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $TSHA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$TSHA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE) |
-8.23%
|
| May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN) |
-4.76%
|
| Mar 19, 2026 Earnings Release 2026-03-19 (BEFORE OPEN) |
+2.25%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
-3.81%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN) |
+0.72%
|
| May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN) |
+5.91%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (BEFORE OPEN) |
+5.88%
|
| Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE) |
-9.05%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
14.8%
Bullish Gaps (8)
Bearish Gaps (5)
Neutral / Flat (1)
📖 Intelligence Summary
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing….
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗